IDEA Design reaches a new European milestone in healthcare design
Home News IDEA Design reaches a new European milestone in healthcare design

IDEA Design reaches a new European milestone in healthcare design

JULY 17, 2026 Members' News

IDEA Design has reached a new milestone in the iF Design Ranking 2022–2026, placing 11th among 76 European design and architecture studios in the Medical/Healthcare category, and ranking as the leading Spanish company in this classification.

The iF Design Ranking measures accumulated results from the last five years of the iF DESIGN AWARDS, identifying the brands, companies and studios that have achieved sustained recognition over time.

For IDEA Design, this recognition reflects a long-term commitment to one of the most demanding fields of design: product development applied to health.

Designing for MedTech and healthcare means making decisions with real consequences. These decisions affect safety, usability, manufacturability, validation, clinical adoption and the confidence of the people who will ultimately use the product.

In this context, design is not understood as a final layer of the process, but as a way to structure complexity. It helps translate scientific knowledge, technology and innovation into solutions that can be understood, manufactured, validated and brought closer to the market.

IDEA Design's public profile on iF Design currently includes 6 iF Awards, contributing to its position in the ranking. This milestone adds to a broader international track record, with more than 30 design awards received over the last five years, strengthening the company’s positioning in design, innovation and product development.

Beyond the awards, this recognition is connected to the company’s way of working: supporting companies, startups and institutions from early-stage uncertainty to the materialisation of real products. Products that must respond to human needs, technical requirements, industrial processes, regulatory criteria and business objectives.

In healthcare, every detail matters because every detail can influence the experience, safety or viability of a solution.

IDEA Design shares this milestone with the MedTech and HealthTech ecosystem as a sign of its commitment to responsible, rigorous and impact-oriented design.

When medical technology becomes a product that is understandable, reliable and ready to be used, design has fulfilled an essential part of its role.

 

 

November 20, 2026 Members' News
Derm2check Breaks Away From One-Sided AI Skin Apps
Dutch platform combines a free AI skin check with an international network of dermatologists, from first suspicion to treatment Derm2check is the result of a pilot phase of about a year, during which broad experience was built up worldwide in digital dermatological care. That practical experience has now been incorporated into a fully renewed platform, which combines AI technology with a free AI Check for users.
Read more
November 20, 2026 Members' News
SMED Clinical Research joins the Barcelona & Madrid Health Hub
Joining Barcelona & Madrid Health Hub marks an important step for SMED Clinical Research as the company continues to strengthen its presence within the healthcare and life sciences ecosystem. It creates new opportunities to stay close to innovation, collaborate with leading organisations, and better understand the evolving needs of sponsors, clinical sites and the patients they serve.
Read more
November 19, 2026 Members' News
Partner Insights 2026: Technology, Innovation and Collaboration in Life Sciences
Ambit Iberia has launched Partner Insights 2026, the new edition of its annual magazine bringing together the perspectives of 13 technology partners on the trends, challenges and opportunities shaping the future of the Life Sciences industry.
Read more
November 19, 2026 Members' News
Artificial Intelligence comes to informed consent to answer patients’ questions before surgery
Informed consent is a routine process in any hospital, but its management continues to generate costs, administrative workload and traceability issues when carried out on paper. To address these challenges, ASHO has developed a new end-to-end informed consent management platform that digitizes the entire process and gives patients a more active role, allowing them to access the information in advance, resolve their questions before signing and arrive at surgery with a better understanding of the procedure.
Read more
November 18, 2026 Members' News
Corporate Nutrition for Every Type of Work. The Great Blind Spot in Workplace Wellness
Do we really take care of all the factors that influence team well-being? In recent years, companies have made progress in mental health, work-life balance, flexibility, and creating healthier work environments. However, there is one element that often remains outside the strategy or is treated in a merely informative way: nutrition during the workday.
Read more
November 16, 2026 Members' News
M2H brings exercise prescription into Primary Care: doctors and exercise specialists, finally on a single digital layer
The Barcelona-based healthtech startup, a new member of Barcelona & Madrid Health Hub, connects family doctors and Physical Exercise Specialists within the same clinical workflow, keeping full patient traceability.
Read more
November 13, 2026 Members' News
Fund It, Build It, Certify It: A MedTech Startup's Roadmap to Market
Most MedTech startups don't stall because the technology fails. They stall because funding and regulation were planned separately. Under MDR, compliance is not the last step before submission. It shapes your product and company decisions from day one. And investors know it: before a Series A or B, they expect a credible regulatory strategy, not just a promising prototype. That's why, QbD Group and Capital Cell teamed up, to bring both sides together in one free webinar live session.
Read more
November 13, 2026 Members' News
The Ultimate Guide for Choosing an Enterprise CMS
In strictly regulated industries like pharmaceutical and health insurance, delivering seamless, compliant digital experiences—from patient portals to provider resources—is critical. Magnolia is a leading composable Digital Experience Platform (DXP) trusted by healthcare and global enterprise giants like Sanofi and Generali. By centralizing websites, portals, and apps into one intuitive, open platform, Magnolia's CMS empowers IT teams to build freely and marketing teams to launch faster—all while protecting brand integrity and compliance.
Read more
November 12, 2026 Members' News
Health Tech Enterprise launches half-price UK market entry offer for Barcelona & Madrid Health Hub members
Health Tech Enterprise introduces an exclusive UK Market Entry Pathfinder offer for Barcelona & Madrid Health Hub members, helping MedTech companies assess their readiness for UK expansion and receive an evidence-based market entry recommendation within 21 days, with preferential member pricing available until 31 December 2026.
Read more
November 12, 2026 Members' News
Your Next Innovation May Already Exist
Connecting business challenges with scientific knowledge
Read more